Catalin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1949-2018
0102019492017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Agilla is a mobile agent middleware for sensor networks. Mobile agents are special processes that can migrate across sensors… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2015
2015
Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma Georgina V Long, Victoria Atkinson, Paolo… (More)
Is this relevant?
2011
2011
PURPOSE In this study, we investigated the biochemical pharmacology of pirenoxine (PRX) and catalin under in vitro selenite… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2010
2010
The present investigation studied the efficacy of Catalin eye drops (Senju Pharmaceutical Co, Osaka, Japan) in patients with… (More)
Is this relevant?
2009
2009
This paper presents the design, deployment, and empirical study of a wireless clinical monitoring system that collects pulse and… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2006
2006
Gkika, Dimitra, Catalin N. Topala, Joost G. J. Hoenderop, and René J. M. Bindels. The immunophilin FKBP52 inhibits the activity… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
AIM OF THE STUDY Evaluation of effectiveness of Catalin eye drops in inhibition of cataract or eventual influence on regression… (More)
Is this relevant?
1999
1999
PURPOSE To find out the role of Catalin in the prevention of posterior capsular opacification (PCO), we undertook this… (More)
Is this relevant?
1990
1990
The antioxidative effect of various drugs on lipid peroxidation in rat serum in the presence of FeSO4 was studied. The… (More)
Is this relevant?
1987
1987
Substances derived from biotransformation of non-steroid antiinflammatory drugs (NSAID) produced by patients responsive to the… (More)
Is this relevant?